---
title: Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab
date: '2024-09-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39291212/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240918184842&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: This is the first real-world cohort analysis of data from
  patients treated with ravulizumab and reinforces the real-world safety and effectiveness
  data of ravulizumab in patients with aHUS who switched from ...'
disable_comments: true
---
CONCLUSION: This is the first real-world cohort analysis of data from patients treated with ravulizumab and reinforces the real-world safety and effectiveness data of ravulizumab in patients with aHUS who switched from ...